Attached files
| file | filename |
|---|---|
| EX-17.1 - EX-17.1 - EMMAUS LIFE SCIENCES, INC. | a15-17677_1ex17d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 10, 2015
Emmaus Life Sciences, Inc.
(Exact Name of Registrant as Specified in Its Charter)
|
Delaware |
|
000-53072 |
|
41-2254389 |
|
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
of Incorporation) |
|
|
|
|
21250 Hawthorne Boulevard, Suite 800, Torrance, CA 90503
(Address, including zip code, off principal executive offices)
Registrant’s telephone number, including area code 310-214-0065
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 10, 2015, Henry A. McKinnell, Jr., Ph.D., member of the Board of Directors (the “Board”) of Emmaus Life Sciences, Inc. (the “Company”), tendered his resignation from the Board, effective as of close of business on August 14, 2015 which has subsequently been extended to August 19, 2015. Prior to his resignation, Dr. McKinnell was a member of the Board’s Audit and Compensation, Nominating and Corporate Governance Committees.
Dr. McKinnell’s resignation is not due to any disagreement with the Company or its management.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.
|
Exhibit No. |
|
Description |
|
|
|
|
|
17.1 |
|
Resignation Letter of Henry A. McKinnell, Jr., Ph.D. which has subsequently been extended to August 19, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
EMMAUS LIFE SCIENCES, INC. | ||
|
|
| ||
|
|
| ||
|
Date: August 14, 2015 |
| ||
|
|
| ||
|
|
| ||
|
|
By: |
/s/Peter Ludlum | |
|
|
Name: |
Peter Ludlum | |
|
|
Title: |
Chief Financial Officer | |